Frontlight ResearchEarly access
What researchers published on Polymyalgia rheumatica
1,081 papers, newest first.
Showing 20 of 1,081
Analgesic prescribing in people with polymyalgia rheumatica: a retrospective cohort study in the Clinical Practice Research Datalink.Rheumatology advances in practice
Case report[Prednisone-responsive pure red cell aplasia associated with polymyalgia rheumatica].[Rinsho ketsueki] The Japanese journal of clinical hematology
Case report[68Ga]Ga-FAPI-46 PET/CT and [18F]FDG PET/CT in polymyalgia rheumatica, ovarian teratoma, and reactive peritoneal lesions: a case report.BJR case reports
Treatment patterns and outcomes of immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: a single-centre observational study.RMD open
Influence of Sex on Glucocorticoid Toxicity Profiles in Polymyalgia Rheumatica.ACR open rheumatology
ReviewMore is less: Glucocorticoid-sparing agents in polymyalgia rheumatica.Therapeutic advances in musculoskeletal disease
Single-cell transcriptome sequencing analysis of peripheral blood mononuclear cells reveals immune signatures in patients with polymyalgia rheumatica.Frontiers in immunology
Case report[A CASE OF POLYMYALGIA RHEUMATICA (PMR)-LIKE irAE DEVELOPING DURING NIVOLUMAB ADMINISTRATION AFTER SURGERY FOR MUSCLE-INVASIVE BLADDER CANCER : A CASE REPORT].Hinyokika kiyo. Acta urologica Japonica
ReviewEfficacy and Safety of Janus Kinase Inhibitors in Polymyalgia Rheumatica: A Systematic Review.Cureus
International recommendations for the use of imaging in the diagnosis and assessment of polymyalgia rheumatica.Annals of the rheumatic diseases
Conversion surgery after atezolizumab plus bevacizumab therapy for postoperative pulmonary metastasis of hepatocellular carcinoma complicated by polymyalgia rheumatica as an immune-related adverse event.Clinical journal of gastroenterology
Case reportPostoperative polymyalgia rheumatica after lung cancer resection in the absence of immune checkpoint inhibitors: A case report and literature review.Experimental and therapeutic medicine
JAK Inhibitors, Anti-IL-6R Antagonists, Secukinumab, Abatacept, and Rituximab in Polymyalgia Rheumatica: What Insights Emerge from Phase 2 and 3 Randomized Controlled Trials?Medicines (Basel, Switzerland)
Frailty characterization and patient-reported outcomes in patients with immune checkpoint inhibitor-related inflammatory arthritis and polymyalgia rheumatica.Rheumatology advances in practice
Targeted Therapies in Polymyalgia Rheumatica: From Immunopathophysiology to a Redefined Treatment Paradigm.Drugs
Meta-analysisOccurrence and clinical course of immune checkpoint inhibitor-associated inflammatory arthritis and polymyalgia rheumatica-like syndromes: a systematic review and meta-analysis.Frontiers in immunology
Beyond disease labels: towards a stratified spectrum model for giant cell arteritis and polymyalgia rheumatica.Rheumatology (Oxford, England)
Comment on:18F-fluorodeoxyglucose PET/CT uptake characteristics in ICI-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica.Clinical and experimental rheumatology
Therapeutic divergence between polymyalgia rheumatica and giant cell arteritis: lessons from IL-17A inhibition.Clinical and experimental rheumatology
GuidelineThe 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica.Rheumatology (Oxford, England)
In plain wordsRead moreRead the paper on PubMed